# Terremoto funding rounds and investors

As of 14 Oct 2026, Terremoto has raised $108M across 1 verified round on record; latest: $108 million Series C, announced 15 Apr 2026.

Cutting-edge small-molecule therapies for cancer and other diseases targeted primarily at healthcare providers and researchers.

Website: https://terremotobio.com  
Headquarters: South San Francisco, California  
Page: https://fireround.dev/companies/terremotobio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-04-15 | Series C | $108 million | not stated | BeOne Medicines, Cormorant Capital, Deep Track Capital, Novo Holdings, OrbiMed, Osage University Partners, RA Capital Management, Third Rock Ventures | [terremotobio.com](https://terremotobio.com/press-release/terremoto-biosciences-closes-108-million-series-c-financing-to-advance-selective-akt1-inhibitors-in-oncology-and-hereditary-hemorrhagic-telangiectasia) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.